Y.D. More Investments’s AbbVie ABBV Stock Holding History

Y.D. More Investments’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$125K	Sell	576 -449	-44%	-$99.6K	﹤0.01%	236
2025 Q4	$234K	Sell	1,025 -205	-17%	-$46.7K	0.01%	189
2025 Q3	$285K	Sell	1,230 -87	-7%	-$17.7K	0.02%	177
2025 Q2	$242K	Sell	1,317 -91	-6%	-$16.9K	0.02%	186
2025 Q1	$295K	Buy	1,408 +39	+3%	+$7.58K	0.03%	178
2024 Q4	$243K	Buy	1,369 +198	+17%	+$36.4K	0.02%	178
2024 Q3	$231K	Buy	1,171 +38	+3%	+$7.09K	0.02%	181
2024 Q2	$194K	Buy	1,133 +763	+206%	+$126K	0.02%	186
2024 Q1	$67.4K	Hold	370	–	–	0.01%	223
2023 Q4	$57.3K	Hold	370	–	–	0.01%	230
2023 Q3	$55.2K	Sell	370 -280	-43%	-$41.1K	0.01%	231
2023 Q2	$87.6K	Sell	650 -141	-18%	-$20.7K	0.02%	184
2023 Q1	$126K	Buy	791 +500	+172%	+$76.4K	0.03%	163
2022 Q4	$47.3K	Buy	+291	New	+$44.6K	0.01%	252

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Y.D. More Investments's ABBV Position: Q1 2026 in Review

Y.D. More Investments reduced its AbbVie (ABBV) stake by 44% in Q1 2026, selling an estimated $99.6K and leaving 576 shares worth $125K. The position accounts for ﹤0.01% of the portfolio, ranked #236.

Y.D. More Investments first reported a position in ABBV in Q4 2022 and has held it in 14 quarters since. The position peaked at $295K in Q1 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Y.D. More Investments held 576 shares of AbbVie worth $125K as of Q1 2026.
Y.D. More Investments sold 449 AbbVie shares in Q1 2026, an estimated $99.6K.
AbbVie made up ﹤0.01% of Y.D. More Investments's portfolio in Q1 2026, its #236 holding.
Y.D. More Investments first reported a position in AbbVie in Q4 2022 and has held it in 14 quarters since.
Y.D. More Investments's AbbVie position peaked at $295K in Q1 2025.
4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Y.D. More Investments's 13F filing for Q1 2026, filed 4 May 2026.